QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: mol.106.025759v1 70/5/1812    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ciucci, A. Articles by Santoro, M. G. Search for Related Content PubMed PubMed Citation Articles by Ciucci, A. Articles by Santoro, M. G.

Induction of Apoptosis in Estrogen Receptor-Negative Breast Cancer Cells by Natural and Synthetic Cyclopentenones: Role of the IB Kinase/Nuclear Factor-B Pathway

Department of Biology, University of Rome, Rome, Italy (A.C., P.G., R.P., M.G.S.); Department of Chemistry, University of Liverpool, Liverpool, United Kingdom (T.G.); and School of Chemistry, University of Manchester, Manchester, United Kingdom (T.J.S., S.M.R.)

Nuclear factor-B (NF-B), a transcription factor with a critical role in promoting inflammation and cell survival, is constitutively activated in estrogen-receptor (ER)-negative breast cancer and is considered a potential therapeutic target for this type of neoplasia. We have previously demonstrated that cyclopentenone prostaglandins are potent inhibitors of NF-B activation by inflammatory cytokines, mitogens, and viral infection, via direct binding and modification of the subunit of the IB kinase complex (IKK). Herein, we describe the NF-B-dependent anticancer activity of natural and synthetic cyclopentenone IKK inhibitors. We demonstrate that the natural cyclopentenone 15-deoxy-^12,14prostaglandin J₂ (15d-PGJ₂) is a potent inhibitor of constitutive IB-kinase and NF-B activities in chemotherapy-resistant ER-negative breast cancer cells. 15d-PGJ₂-induced inhibition of NF-B function is rapidly followed by down-regulation of NF-B-dependent antiapoptotic proteins cIAPs 1/2, Bcl-X_L, and cellular FLICE-inhibitory protein, leading to caspase activation and induction of apoptosis in breast cancer cells resistant to treatment with paclitaxel and doxorubicin. We then demonstrate that the cyclopentenone ring structure is responsible for these activities, and we identify a new synthetic cyclopentenone derivative, 3-tert-butyldimethylsilyloxy-5-(E)-iso-propylmethylenecyclopent-2-enone (CTC-35), as a potent NF-B inhibitor with proapoptotic activity in ER-negative breast cancer cells. The results open new perspectives in the search for novel proapoptotic molecules effective in the treatment of cancers presenting aberrant NF-B regulation.

Address correspondence to: Dr. M. Gabriella Santoro, Department of Biology, University of Rome Tor Vergata, Via della Ricerca Scientifica, 00133 Rome, Italy. E-mail: santoro{at}bio.uniroma2.it

This article has been cited by other articles:

				S. Singh, Q. Shi, S. T. Bailey, M. J. Palczewski, A. B. Pardee, J. D. Iglehart, and D. K. Biswas Nuclear factor-{kappa}B activation: a molecular therapeutic target for estrogen receptor-negative and epidermal growth factor receptor family receptor-positive human breast cancer Mol. Cancer Ther., July 1, 2007; 6(7): 1973 - 1982. [Abstract] [Full Text] [PDF]